Publication Year: 2021
-
Predicting prognosis in COVID-19 patients using machine learning and readily available clinical data
-
Detection of Hepatocellular Carcinoma in a High-Risk Population by a Mass Spectrometry-Based Test
-
Potential role of serum proteome in predicting immune-related adverse events from immunotherapy in non-small cell lung cancer
-
Longitudinal blood-based proteomic testing in advanced non-small cell lung cancer
-
Old Habits Die Hard: Managing Lung Nodules With Size Alone Is Not Sufficient
-
Utilizing Serum Proteome to Understand Response and Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
-
The Impact of Blood-Based Host Immune Profiling to Identify Aggressive Early-Stage NSCLC
-
Immunotherapy Alone or with Chemotherapy in Advanced NSCLC? Utility of Clinical Factors and Blood-Based Host Immune Profiling
-
Targeted Next-Generation Sequencing of Liquid Biopsy Samples from Patients with NSCLC